Healthcare & Life Sciences
Endeavor BioMedicines
United Statesendeavorbiomedicines.com/
Endeavor BioMedicines is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Endeavor BioMedicines
Based in the United States, Endeavor BioMedicines is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Endeavor BioMedicines is a clinical-stage biotechnology company developing therapeutic candidates targeting the Hedgehog signaling pathway, with its lead drug taladegib (ENV-101) in clinical trials for fibrotic lung diseases such as idiopathic pulmonary fibrosis.
Explore Endeavor BioMedicines's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.